fbpx
Print this page
Wednesday, 28 August 2013 16:36

Fonterra recall false alarm, MPI tests show

Written by 

The Ministry for Primary Industries has received results confirming the bacteria found in the whey protein concentrate (WPC) manufactured by Fonterra is not Clostridium botulinum.

The organism is confirmed as Clostridium sporogenes. It is therefore not capable of producing botulism causing toxins.

There are no known food safety issues associated with Clostridium sporogenes, although at elevated levels certain strains may be associated with food spoilage.

"When MPI received information from Fonterra on 2 August that it had detected Clostridium botulinum in some of its products, I immediately adopted a precautionary approach to protect consumers both here and overseas," acting director-general Scott Gallacher says.

"We needed to act on what we knew at that time. The information we had then said there was a food safety risk to consumers and we moved quickly to address it."

At the same time, MPI commissioned a further array of tests to validate the initial results Fonterra reported. A total of 195 tests using a range of technologies have been conducted in laboratories here and in the USA. Results from the most definitive of these tests arrived over night, and were assessed with appropriate technical advice on hand today.

"We sought additional testing at both local and international laboratories, seeking the most robust results we could get. Scientists used a range of methods – all came back negative for Clostridium botulinum," says Gallacher.

"MPI has today informed overseas regulators of these results, and we will be providing them with a full diagnostic report shortly. I will also be revoking my Director-General's statement, issued under the Food and Animal Products Acts, about this issue."

A failure of hygiene during processing remains a concern for customers incorporating WPC into their products. However, the concern primarily relates to quality and the potential for spoilage when used in foods that support growth of Clostridium sporogenes from spores.

More like this

Fonterra names Templeman-Jones to Mainland Group board amid divestment

As part of preparing for a potential IPO in relation to the divestment process for its global Consumer business and integrated businesses Fonterra Oceania and Sri Lanka, Fonterra has named Anne Templeman-Jones as chair-elect of the Audit and Risk Committee for the Mainland Group board.

Featured

National

Machinery & Products

Farmer-led group buys Novag

While the name and technology remain unchanged and new machines will continue to carry the Novag name, all the assets,…

Buhler name to go

Shareholders at a special meeting have approved a proposed deal that will see Buhler Industries, the publicly traded Versatile and…